Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.
AIMS: The autoantigen SOX-13 of the SRY-related high mobility group box is a low-frequency reactant in sera from patients with Type 1 diabetes. We further investigated the potential diagnostic role of anti-SOX-13, and in particular its ability to distinguish Type 1 from Type 2 diabetes, in two large...
मुख्य लेखकों: | Davis, T, Mehta, Z, Mackay, I, Cull, C, Bruce, D, Fida, S, Rowley, M, Holman, R |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2003
|
समान संसाधन
-
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
द्वारा: Davis, T, और अन्य
प्रकाशित: (2005) -
Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
द्वारा: Mehta, Z, और अन्य
प्रकाशित: (1999) -
Autoantibodies to islet amyloid polypeptide in diabetes.
द्वारा: Clark, A, और अन्य
प्रकाशित: (1991) -
Prevalence of islet autoantibodies in type 1 diabetes
द्वारा: Devi Dayal, और अन्य
प्रकाशित: (2017-01-01) -
Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
द्वारा: Young Hwa Kong, और अन्य
प्रकाशित: (2013-06-01)